The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model

Archives of Gynecology and Obstetrics

Volumn 291, Issue 3, 2015, Pages 591-598

  Cetinkaya, Nilufer ^a   Attar, Rukset ^b   Yildirim, Gazi ^b   Ficicioglu, Cem ^b   Ozkan, Ferda ^b   Yilmaz, Bayram ^b   Yesildaglar, Narter ^c  

^a Zekai Tahir Burak Women's Health Training and Education Hospital   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c Sevket Yilmaz Training and Research Hospital   (Turkey)

Author keywords

Endometriosis; Experimental endometriosis model; Melatonin; Rats

Indexed keywords

ESTRADIOL; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE; VASCULOTROPIN; ANTIOXIDANT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIOSIS; ENZYME ACTIVITY; EXPERIMENTAL STUDY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; NONHUMAN; PROSPECTIVE STUDY; RAT; SCORING SYSTEM; ANIMAL; BLOOD; DRUG EFFECTS; HUMAN; METABOLISM; OVARIECTOMY; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIOSIS; FEMALE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MELATONIN; OVARIECTOMY; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84922214840     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3466-3     Document Type: Article

References (40)

1. Bernardi Lia A, Pavone ME (2013) Endometriosis: an update on management. Women’s Health 9(3):233–250
2. Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ (2011) Novel therapies targeting endometriosis. Reprod Sci 18(9):814–823
3. Nap AW, Groothuis PG et al (2004) Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 18(2):233–244
4. Seli E, Arici A (2003) Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med 21(2):135–144
5. Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T (2010) Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep 37(1):369–374
6. Zhang X, Hei P, Deng L, Lin J (2007) Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13(2):135–140
7. Iwabe T, Harada T, Terakawa N (2002) Role of cytokines in endometriosis-associated infertility. Gynecol Obstet Invest 53:19–25
8. Wu MY, Ho HN (2003) The role of cytokines in endometriosis. Am J Reprod Immunol 49:285–296
9. Gupta S, Agarwal A, Krajcir N, Alvarez JG (2006) Role of oxidative stress in endometriosis. Reprod Biomed Online 13:126–134
10. Carvalho LF, Abrão MS, Biscotti C, Sharma R, Nutter B, Falcone T (2013) Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci. 20(6):688–698
11. Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M (2003) Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79:1288–1293
12. Polak G, Koziol-Montewka M, Gogacz M, Tarkowski R, Kotarski J (2001) Total antioxidant status of peritoneal fluid in infertile women. Europ J Obstet Gynecol Reprod Biol 94:261–263
13. Arendt J (1995) Melatonin and the mammalian pineal gland. Chapman & Hall, London
14. Pevet P, Bothorel B, Slotten H, Saboureau M (2002) The chronobiotic properties of melatonin. Cell Tissue Res 309:183–191
15. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA (2006) Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 1757(5–6):573–589
16. Karbownik M, Garcia JJ, Lewinski A, Reiter RJ (2001) Carcinogeninduced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr 33:73–78
17. Reiter RJ, Tan DX, Manchester LC, Qi W (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 34:237–256
18. Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ (2001) Increased level of oxidatively damaged DNA induced by chromium (III) and H2O2: protection by melatonin and related molecules. J Pineal Res 29:54–61
19. Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181–197
20. Guerrero JM, Reiter RJ (2002) Melatonin–immune system relationships. Curr Top Med Chem 2:167–179
21. Esquifino AI, Pandi-Perumal SR, Cardinali DP (2004) Circadian organization of the immune response: a role for melatonin. Clin Appl Immunol Rev 4:423–433
22. Maestroni GJM, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol 13:19–30
23. Maestroni GJM (1998) Is hematopoiesis under the influence of neural and neuroendocrine mechanisms? Histol Histopathol 13:271–274
24. Tamura H, Nakamura Y, Korkmaz A et al (2009) Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 92(1):328–343
25. García-Pergañeda A, Pozo D, Guerrero JM, Calvo JR (1997) Signal transduction for melatonin in human lymphocytes: Involvement of a pertussistoxin sensitive G protein. J Immunol 159:3774–3781
26. Barjavel MJ, Mamdouh Z, Raghbate N, Bakouche O (1998) Differential expression of the melatonin receptor in human monocytes. J Immunol 160:1191–1197
27. Srinivasan V, Maestroni GJ, Cardinali DP, Esquifino AI, Perumal SR, Miller SC (2005) Melatonin, immune function and aging. Immun Ageing 2:17
28. Petrovsky N, Harrison L (1998) The chronobiology of human cytokine production. Int Rev Immunol 16:635–649
29. Raghavendra V, Singh V, Kulkarni SK, Agrewala JN (2001) Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 221:57–62
30. Kang JC, Ahn M, Kim YS, Moon C, Lee Y, Wie MB et al (2001) Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci 2:85–89
31. Voznesenskaya T, Makogon N, Bryzgina T, Sukhina V, Grushka N, Alexeyeva I (2007) Melatonin protects against experimental immune ovarian failure in mice. Reprod Biol 7:207–220
32. Guney M, Oral B, Karahan N, Mungan T (2008) Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 89:934–942
33. Yildirim G, Attar R, Ozkan F, Kumbak B, Ficicioglu C, Yesildaglar N (2010) The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study. Fertil Steril 93:1787–1792
34. Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudleb MR, Bukovsky A (1999) Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72:135–141
35. Kocadal NC, Attar R, Yıldırım G, Fıçıcıoğlu C, Özkan F, Yılmaz B, Yesildaglar N (2013) Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model. JTGGA 14(2):81–86
36. Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C (2013) An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 14(3):291–305 (Review)
37. Hughes E, Fedorkow D, Collins J, Vandekerckhove P (2003) Ovulation suppressionfor endometriosis. Cochrane Database Syst Rev 3:CD000155
38. Hardeland R, Pandi-Perumal SR, Cardinali DP (2006) Melatonin. Int J Biochem Cell Biol 38:313–316
39. Schwertner A, Conceicao Dos Santos CC, Costa GD, Deitos A, de Souza A, de Souza IC et al (2013) Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. Pain 154(6):874–881
40. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Swarnakar S (2008) Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44:439–449